Results 221 to 230 of about 454,057 (403)

Weight Loss With GLP‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis

Obesity, EarlyView.
ABSTRACT Objective Two glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) (semaglutide and liraglutide) and one dual agonist (tirzepatide) are FDA‐approved for weight loss in adults with obesity without type 2 diabetes mellitus. This systematic review and network meta‐analysis aims to compare the efficacy of these agents against each other.
Michael Lim, Pooja Gokhale, Akwasi Akosah, Lorenzo Villa‐Zapata   +3 more
wiley   +1 more source

Coexistence of Resistance to Thyroid Hormone and a Thyroid Stimulating Hormone-Secreting Pituitary Adenoma. [PDF]

AACE Endocrinol Diabetes
Koo TH, Gharib H.
europepmc   +1 more source

Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.

Journal of the National Cancer Institute, 2014
S. Rinaldi, M. Plummer, C. Biessy, K. Tsilidis, K. Tsilidis, J. Østergaard, K. Overvad, A. Tjønneland, Jytte Halkjær, M. Boutron‐Ruault, F. Clavel-Chapelon, L. Dossus, R. Kaaks, A. Lukanova, H. Boeing, A. Trichopoulou, P. Lagiou, P. Lagiou, D. Trichopoulos, D. Trichopoulos, D. Palli, C. Agnoli, R. Tumino, P. Vineis, S. Panico, H. Bueno-de-Mesquita, P. Peeters, E. Weiderpass, E. Lund, J. Quirós, A. Agudo, E. Molina, N. Larrañaga, C. Navarro, E. Ardanaz, J. Manjer, M. Almquist, M. Sandström, J. Hennings, K. Khaw, Julie A. Schmidt, R. Travis, G. Byrnes, A. Scalbert, I. Romieu, M. Gunter, E. Riboli, S. Franceschi   +47 more
semanticscholar   +1 more source

The association of thyroid-stimulating hormone (TSH) and free thyroxine (fT4) concentration levels with carbohydrate and lipid metabolism in obese and overweight teenagers.

, 2019
Katarzyna Korzeniowska, Michał Brzeziński, Kamila Szarejko, Marcin Radziwiłł, Tomasz Anyszek, Leszek Czupryniak, Piotr Soszyński, Per‐Olof Berggren, Małgorzata Myśliwiec   +8 more
openalex   +2 more sources

Association between Serum Thyroid Stimulating Hormone Level and Papillary Thyroid Microcarcinoma in Korean Euthyroid Patients [PDF]

, 2011
Hyun Sook Kim, Seung Joon Lee, Jung Kyu Park, Chang Ho Jo, Ho Sang Shon, Eui Dal Jung   +5 more
openalex   +1 more source

Evidence map and gap analysis of metabolic change in pediatric growth hormone deficiency treated with growth hormone

Pediatric Investigation, EarlyView.
This evidence map of 63 studies (n = 6158) showed growth hormone therapy in children with growth hormone deficiency has neutral glucose effects, mixed lipid outcomes, potential benefits for bone mineral density, bone mineral content, and parathyroid hormone, but generally no impact on thyroid function, body composition, or body mass index.
Wei Wu, Ningyi Song, Yue Zhao, Caiqi Du, Yuning Zhao, You Wu, Xiaoping Luo   +6 more
wiley   +1 more source

Performance evaluation and reference interval establishment of Abbott Alinity thyroid-stimulating hormone receptor antibody (TRAb) assay for diagnosing Graves' disease. [PDF]

PLoS One
Xue H, Li B, Wang X, Zhao J, Yan Y, Lao J, Ji L, Xia Y.   +7 more
europepmc   +1 more source

Thyroid-stimulating hormone reference intervals in the first trimester in an iodine-sufficient population of pregnant women attended by the public health system in Curitiba, South of Brazil

Bianca Chames Ozaki, Paulo Cesar Zimmermann Felchner, Tatiane Mendes Boutin Bartneck Telles, Cléo Otaviano Mesa, Kelis Daiane Valdati, Tamara Matzembacher Panizza, Thyago Proença de Moraes   +6 more
openalex   +1 more source

Effect of nonsurgical periodontal therapy on thyroid stimulating hormone in hypothyroid patients with periodontal diseases

, 2017
RuchiRamesh Bhankhar, Shital Hungund, Preeti Kambalyal, Vatsala Singh, Kushal Jain   +4 more
openalex   +1 more source

Multiple eumenorrheic cycles are necessary to observe a significant increase in estrogen exposure and ovulation in exercising women with functional hypothalamic oligo/amenorrhea undergoing a nutritional intervention: Insights from the REFUEL study

PM&R, EarlyView.
Abstract Background Due to consequences of energy‐related oligo‐/amenorrhea (Oligo/Amen) among exercising females, recovery of menses (ROM) is a priority. ROM is inconsistently defined and rarely reported with reproductive hormone (estrogen, progesterone) data, making it difficult to know when females achieve adequate recovery. Objective The purpose of
Rebecca J. Mallinson, Nancy I. Williams, Emily A. Ricker, Heather C. M. Allaway, Mary Jane De Souza   +4 more
wiley   +1 more source